ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $13,000 | -13.3% | 285 | -53.3% | 0.01% | -12.5% |
Q1 2019 | $15,000 | +15.4% | 610 | 0.0% | 0.01% | +14.3% |
Q4 2018 | $13,000 | +18.2% | 610 | -15.3% | 0.01% | +16.7% |
Q3 2018 | $11,000 | -8.3% | 720 | 0.0% | 0.01% | -14.3% |
Q2 2018 | $12,000 | 0.0% | 720 | -2.7% | 0.01% | 0.0% |
Q1 2018 | $12,000 | +33.3% | 740 | 0.0% | 0.01% | +40.0% |
Q4 2017 | $9,000 | -99.9% | 740 | +27.6% | 0.01% | -37.5% |
Q3 2017 | $13,407,000 | +47.0% | 580 | -46.8% | 0.01% | +33.3% |
Q2 2017 | $9,123,000 | -1.4% | 1,090 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $9,254,000 | +92440.0% | 1,090 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $10,000 | +150.0% | 1,090 | 0.0% | 0.01% | +100.0% |
Q2 2016 | $4,000 | +100.0% | 1,090 | +113.7% | 0.00% | +200.0% |
Q1 2016 | $2,000 | – | 510 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |